Education
About Us
Working with TipRanks
Follow Us
Evgen Pharma PLC (GB:TCF)
LSE:TCF
Fulvestrant, Tamoxifen, Sfx-01, Aromatase Inhibitors
Breast Neoplasm
Phase II
Completed
SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer
Nov 15, 2016
―
Sfx-01
Subarachnoid Hemorrhage, Spontaneous
Phase II
Completed
SFX-01 After Subarachnoid Haemorrhage
Nov 16, 2015
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Evgen Pharma PLC (TCF) have in its pipeline
TCF is currently developing the following drugs: Fulvestrant, Tamoxifen, Sfx-01, Aromatase Inhibitors, Sfx-01. These drug candidates are in various stages of clinical development as the company works toward FDA approval.